The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Increasing demand from customers for dental bone graft substitutes, growing inclination towards cosmetic dentistry, and rising industry standards are spurring the growth of the dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of the dental bone grafts substitutes market.
https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html
The global dental bone graft substitutes market is segmented on the basis of type, application, and region. The geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). RoW includes Latin America, the Middle East, and Africa.
On the basis of type, the dental bone graft substitutes market has been segmented into synthetic bone graft, xenograft, allograft, and demineralized allograft. The shift from autografts to allografts and further usage of synthetic and tissue engineered bone grafts due to the technological advancements taking place in the medical sector are propelling the growth of the market.
The xenograft segment is estimated to account for the largest share of the global dental bone graft substitutes market in 2016. Benefits, such as easy availability, sterility, reduced morbidity, long shelf life, and reduced risks of disease transfer offered by synthetic grafts are leading towards their increased usage as dental bone graft substitutes.
Dental bone graft substitutes are mainly used in ridge augmentation, socket preservation, periodontal defect regeneration, implant bone regeneration, and sinus lift procedures. The socket preservation application segment is estimated to account for the largest share of the market in 2016.
Socket preservation is a procedure that is used to reduce bone loss from tooth socket in alveolar bone after tooth extraction. Increasing number of dental implant procedures and growing awareness among people about oral care are the factors driving growth of this segment of the dental bone graft substitutes market.
DOwnload PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=159678690
Bio-Oss is one of the leading products in the dental bone graft substitutes market. It is manufactured using organic components obtained from bovine bone, which is similar to human bone. It is porous and non-antigenic in nature. This product is easy to apply and has its application areas in extraction sockets, horizontal augmentation, peri-implant defects, periodontal regeneration, ridge augmentation, sinus floor elevation, and vertical augmentation. Geistlich Holding is engaged in the manufacturing and production of Bio-Oss.
The European region is estimated to account for the largest share of the dental bone graft substitutes market in 2016. As implant dentistry originated in the European region, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the Europe market are the continuous increase in aging population, governmental expenditure on oral healthcare across the region, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.
The dental bone graft substitutes market is a competitive market with a large number of companies operational in the market. The competitive landscape includes an in-depth market share analysis along with the key business strengths of the leading market players. Some of the leading players offering dental bone graft substitutes products are Geistlich Pharma AG (Switzerland), Zimmer Dental Inc. (U.S.), Dentsply Sirona (U.S.), LifeNet Health (U.S.), RTI Surgical, Inc. (U.S.), BioHorizons IPH, Inc. (U.S.), and ACE Surgical Supply Company, Inc. (U.S.).
No comments:
Post a Comment